Topic Paragraphs
FDA Covid-19 Response
FDA is working with U.S. Government partners, including CDC, and international partners to address the pandemic.
Featured Topics
New Era of Smarter Food Safety
A new approach to food safety that recognizes and builds on the progress made in the past but looks towards what processes and tools will be needed for the future.
Fostering Drug Competition
Increasing the availability of generic drugs helps to create competition in the marketplace, helping make treatment more affordable and increasing access to healthcare for more patients.
Combating the Opioid Crisis
FDA takes actions to combat prescription opioid abuse.
Recent Press Announcements
Recalls, Market Withdrawals, & Safety Alerts
The FDA provides information gathered from press releases and other public notices about certain recalls of FDA-regulated products. Not all recalls have press releases or are posted on this website
Mar 11
Allergy Alert Issued for Undeclared Tree Nuts in Mislabeled Cranberry Biscotti at Six Whole Foods Market Stores
Food & Beverages
Mar 11
Sagent Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Phenylephrine Hydrochloride Injection, USP, 10 mg/mL Due to Potential Lack of Sterility Assurance
Drugs
Mar 10
MG Foods Recalls Various Turkey Sandwiches Due to Possible Listeria monocytogenes Contamination
Food & Beverages
Paragraph Header
FDA VOICES: PERSPECTIVES FROM FDA EXPERTS
Elastomeric Respirator Innovations Play a Critical Role in Response to COVID-19
Elastomeric respirators can play a critical role in the nation’s response to COVID-19 and bolster future readiness.
FDA’s Data Modernization Action Plan: Putting Data to Work for Public Health
Data modernization is the next step in the agency’s overhaul of its approach to technology and data.
Semana Nacional de Protección al Consumidor: La FDA se mantiene alerta para proteger a los consumidores de las estafas relacionadas con las vacunas contra el COVID-19
Los charlatanes buscan sacar provecho de la pandemia con estafas relacionadas con las vacunas COVID-19.
Recently Published Guidances
Mar 04
COVID-19 Container Closure System and Component Changes: Glass Vials and Stoppers Guidance for Industry
Biologics, Drugs
Feb 22
Development of Monoclonal Antibody Products Targeting SARS-CoV-2, Including Addressing the Impact of Emerging Variants, During the COVID 19 Public Health Emergency
Drugs
Feb 22
Emergency Use Authorization for Vaccines to Prevent COVID-19
Biologics